BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33260421)

  • 41. Characteristics and prognostic factors of COVID-19 among infected cases: a nationwide Tunisian analysis.
    Harizi C; Cherif I; Najar N; Osman M; Mallekh R; Ayed OB; Ayedi Y; Dhaouadi S; Hchaichi A; Safer M; Letaief H; Bouaziz I; Derouiche S; Gharbi D; Bouabid L; Bougatef S; Ben Salah H; Fakhfakh R; Abid S; Ben Boubaker IB; Chahed MK; Ben-Alaya NB
    BMC Infect Dis; 2021 Feb; 21(1):140. PubMed ID: 33535971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling the early temporal dynamics of viral load in respiratory tract specimens of COVID-19 patients in Incheon, the Republic of Korea.
    Lim AY; Cheong HK; Oh YJ; Lee JK; So JB; Kim HJ; Han B; Park SW; Jang Y; Yoon CY; Park YO; Kim JH; Kim JY
    Int J Infect Dis; 2021 Jul; 108():428-434. PubMed ID: 34058374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
    Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
    Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Repetition of microbiological tests in suspect of SARS-CoV-2 infection: utility of a score based on clinical probability].
    Pardo Lledias J; Ayarza L; González-García P; Salmón González Z; Calvo Montes J; Gozalo Marguello M; Hernández Hernández JL; Olmos Martínez JM
    Rev Esp Quimioter; 2020 Dec; 33(6):410-414. PubMed ID: 32935535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2 detection in the lower respiratory tract of invasively ventilated ARDS patients.
    Buetti N; Wicky PH; Le Hingrat Q; Ruckly S; Mazzuchelli T; Loiodice A; Trimboli P; Forni Ogna V; de Montmollin E; Bernasconi E; Visseaux B; Timsit JF
    Crit Care; 2020 Oct; 24(1):610. PubMed ID: 33066801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs.
    Park SY; Yun SG; Shin JW; Lee BY; Son HJ; Lee S; Lee E; Kim TH
    Korean J Intern Med; 2020 Jul; 35(4):793-796. PubMed ID: 32549526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.
    He Y; Luo J; Yang J; Song J; Wei L; Ma W
    Front Cell Infect Microbiol; 2020; 10():445. PubMed ID: 32850506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symptomatic and Asymptomatic Viral Shedding in Pediatric Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Under the Surface.
    DeBiasi RL; Delaney M
    JAMA Pediatr; 2021 Jan; 175(1):16-18. PubMed ID: 32857158
    [No Abstract]   [Full Text] [Related]  

  • 49. SARS-CoV-2 transmission without symptoms.
    Rasmussen AL; Popescu SV
    Science; 2021 Mar; 371(6535):1206-1207. PubMed ID: 33737476
    [No Abstract]   [Full Text] [Related]  

  • 50. Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study.
    Pei L; Chen Y; Zheng X; Gong F; Liu W; Lin J; Zheng R; Yang Z; Bi Y; Chen E
    J Infect Public Health; 2023 Feb; 16(2):182-189. PubMed ID: 36566602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transmissibility and viral replication of SARS-COV-2 in immunocompromised patients.
    Beran A; Zink E; Mhanna M; Abugharbyeh A; Hanrahan J; Duggan J; Assaly R
    J Med Virol; 2021 Jul; 93(7):4156-4160. PubMed ID: 33782995
    [No Abstract]   [Full Text] [Related]  

  • 52. Factors associated with prolonged duration of viral clearance in non-severe SARS-CoV-2 patients in Osaka, Japan.
    Hoffman EN; Kawachi H; Hirayama A; Zhang J; Murayama A; Masui J; Fujita S; Mori Y; Hirayama T; Ohara T; Asada R; Iso H
    Environ Health Prev Med; 2021 Dec; 26(1):115. PubMed ID: 34872493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation of shedding time in laboratory-confirmed COVID-19 cases in South Africa: a population-based record linkage study, March-December 2020.
    Tshabane C; Kuonza L; Mdose H; Musekiwa A; Motaze NV
    Pan Afr Med J; 2023; 46():24. PubMed ID: 38107342
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Tuberculosis on Disease Severity and Viral Shedding Duration in COVID-19 Patients.
    Huang W; Liu P; Yan B; Zheng F; Yang Y; Xi X; Xia L; Shen Y
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exceptionally high COVID-19 viral load and very long duration of shedding in a young pauci-symptomatic child with autism resident in an Italian nursing home.
    Grossi E; Terruzzi V
    J Infect; 2021 Feb; 82(2):e29-e30. PubMed ID: 32841645
    [No Abstract]   [Full Text] [Related]  

  • 56. Asymptomatic COVID-19 in hospital visitors: The underestimated potential of viral shedding.
    Passarelli VC; Faico-Filho K; Moreira LVL; Cunha AP; Carvalho JMA; Barbosa GR; Camargo C; Conte DD; Perosa AH; Bellei N
    Int J Infect Dis; 2021 Jan; 102():412-414. PubMed ID: 33129961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discriminant models for the prediction of postponed viral shedding time and disease progression in COVID-19.
    Li WY; Wang D; Guo Y; Huang H; Zhao H; Kang J; Wang W
    BMC Infect Dis; 2022 Apr; 22(1):366. PubMed ID: 35410139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors influencing viral shedding time in non-severe paediatric infection with the SARS-CoV-2: a single-centre retrospective study.
    Hong P; Li C; Tian X; Che D
    BMJ Paediatr Open; 2023 Oct; 7(1):. PubMed ID: 37827803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Negative Conversion Rate of SARS-CoV-2 Infection.
    Zhang R; Liang H; Tang J
    JAMA Intern Med; 2021 Apr; 181(4):566. PubMed ID: 33252622
    [No Abstract]   [Full Text] [Related]  

  • 60. Quarantine Facility for Patients with COVID-19 with Mild Symptoms in Korea: Experience from Eighteen Residential Treatment Centers.
    Yang Y; Kim H; Hwang J
    J Korean Med Sci; 2020 Dec; 35(49):e429. PubMed ID: 33350187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.